Metis Global Partners, LLC Seagen Inc. Transaction History

Metis Global Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$191.51 - $216.16 $153,016 - $172,711	-799 Reduced 19.36%	3,329 $706,000
Q2 2023 Aug 07, 2023	BUY	$187.64 - $206.25 $221,790 - $243,787	1,182 Added 40.12%	4,128 $794,000
Q1 2023 May 08, 2023	BUY	$127.59 - $203.08 $173,905 - $276,798	1,363 Added 86.1%	2,946 $596,000
Q4 2022 Feb 07, 2023	BUY	$117.37 - $139.17 $185,796 - $220,306	1,583 New	1,583 $203,000
Q2 2022 Aug 08, 2022	BUY	$108.81 - $179.33 $127,307 - $209,816	1,170 New	1,170 $207,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Metis Global Partners, LLC with notifications on news.